ISRG Lower PT to $500 from $590 but remain Buy rated as Q2 results surpassed consensus, however ACA headwinds turned management incrementall
ISRG Lower PT to $500 from $590 but remain Buy rated as Q2 results surpassed consensus, however ACA headwinds turned management incrementally conservative on procedures @ Citi
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.